丁酸钠通过Toll样受体4/核因子-κB p65通路抑制海马小胶质细胞炎症活化
该研究在C57BL/6小鼠脓毒症相关脑病(SAE)模型及BV-2小胶质细胞中观察丁酸钠(NaB)对海马炎症和小胶质细胞活化的影响。动物实验采用盲肠结扎穿孔(CLP)建模,NaB按500 mg×kg-1×d-1于造模前3天及造模后3天每日1次给药。结果NaB改善SAE小鼠7天旷场实验中央区活动距离与时间 [(47.39±15.63)mm vs.(13.45±3.97)mm;(6.12±1.87)s vs.(1.82±0.58)s,均P<0.05],并降低海马TNF-α、IL-1β含量及蛋白表达(均P<0.05);细胞实验中NaB降低LPS诱导的TLR4、p-NF-κB p65及炎症因子表达、升高IκB-α(均P<0.05)。作者认为NaB可拮抗LPS诱导的TLR4活化,抑制p-NF-κB p65核转录和IκB-α降解,减轻小胶质细胞活化与炎症因子分泌,改善脓毒症小鼠海马炎症和远期焦虑样行为。
要点
- SAE模型组造模后7天旷场实验中央区活动距离(13.45±3.97)mm、中央区活动时间(1.82±0.58)s、总移动距离(835.01±669.67)mm均低于假手术组[(161.44±27.00)mm、(13.45±2.17)s、(2254.51±213.45)mm,均P<0.05],提示焦虑样行为。
- NaB预处理及治疗后,SAE小鼠中央区活动距离(47.39±15.63)mm、中央区活动时间(6.12±1.87)s显著高于SAE模型组[(13.45±3.97)mm、(1.82±0.58)s,均P<0.05],总移动距离(1550.59±1004.10)mm与模型组(835.01±669.67)mm差异无统计学意义(P>0.05)。
- SAE模型组术后3天海马TNF-α(119.17±18.40)ng/L、IL-1β(407.89±70.64)ng/L及蛋白表达(TNF-α/GAPDH 1.42±0.50、IL-1β/GAPDH 1.27±0.22)高于假手术组[(90.18±21.17)ng/L、(313.69±34.63)ng/L、0.80±0.08、0.85±0.25,均P<0.05]。
- NaB组术后3天海马TNF-α(64.95±9.10)ng/L、IL-1β(311.94±69.92)ng/L及蛋白表达(TNF-α/GAPDH 1.02±0.36、IL-1β/GAPDH 0.86±0.20)低于SAE模型组[(119.17±18.40)ng/L、(407.89±70.64)ng/L、1.42±0.50、1.27±0.22,均P<0.05]。
- 细胞实验中,LPS组TLR4/GAPDH(0.55±0.12)、p-NF-κB p65/NF-κB p65(0.55±0.05)高于空白对照组(0.33±0.09、0.29±0.04),IκB-α/GAPDH(0.54±0.06)低于对照组(0.81±0.03)(均P<0.05);
适用人群与场景
- 动物实验:6-8周龄C57BL/6小鼠,采用盲肠结扎穿孔(CLP)建立脓毒症相关脑病(SAE)模型;假手术组仅开腹找到盲肠,不穿孔不结扎。
- 细胞实验:小鼠小胶质细胞系BV-2细胞。
诊断标准与关键阈值
- SAE模型复制成功标准:旷场实验显示自主探索能力下降并出现焦虑样行为,即证明SAE模型复制成功。
处置流程与药物剂量
- 动物实验:NaB于造模前按500 mg×kg-1×d-1给药3天,造模后同剂量每日1次给药3天(原文未写明给药途径,摘要提及灌胃给药后结果)。
- 细胞实验:LPS组以1 mg/L LPS处理;NaB治疗组以1 mg/L LPS+5 mmol/L NaB处理。
研究设计与关键结果
- 动物实验:SAE模型组造模后7天旷场实验中央区活动距离(13.45±3.97)mm、中央区活动时间(1.82±0.58)s、总移动距离(835.01±669.67)mm均低于假手术组[(161.44±27.00)mm、(13.45±2.17)s、(2254.51±213.45)mm,均P<0.05]。
- SAE模型组海马神经核大量固缩深染、神经细胞排列紊乱,小胶质细胞胞体明显增大,Iba-1+/TNF-α+阳性细胞数明显增多;NaB组上述病理改变及Iba-1+/TNF-α+阳性细胞数明显减少。
- SAE模型组术后3天海马TNF-α(119.17±18.40)ng/L、IL-1β(407.89±70.64)ng/L及蛋白表达(TNF-α/GAPDH 1.42±0.50、IL-1β/GAPDH 1.27±0.22)高于假手术组[(90.18±21.17)ng/L、(313.69±34.63)ng/L、0.80±0.08、0.85±0.25,均P<0.05];NaB组上述指标低于SAE模型组[(64.95±9.10)ng/L、(311.94±69.92)ng/L、1.02±0.36、0.86±0.20,均P<0.05]。
- NaB组中央区活动距离(47.39±15.63)mm、中央区活动时间(6.12±1.87)s高于SAE模型组[(13.45±3.97)mm、(1.82±0.58)s,均P<0.05];总移动距离(1550.59±1004.10)mm与SAE模型组(835.01±669.67)mm差异无统计学意义(P>0.05)。
- 细胞实验:LPS组TNF-α荧光强度增强,TNF-α/GAPDH(0.39±0.06)、IL-1β/GAPDH(0.27±0.03)、TLR4/GAPDH(0.55±0.12)、p-NF-κB p65/NF-κB p65(0.55±0.05)高于空白对照组(0.20±0.02、0.19±0.01、0.33±0.09、0.29±0.04),IκB-α/GAPDH(0.54±0.06)低于对照组(0.81±0.03)(均P<0.05)。
- NaB处理后BV-2细胞TNF-α荧光强度降低,TNF-α/GAPDH(0.26±0.02)、IL-1β/GAPDH(0.11±0.04)、TLR4/GAPDH(0.28±0.14)、p-NF-κB p65/NF-κB p65(0.29±0.01)低于LPS组(0.39±0.06、0.27±0.03、0.55±0.12、0.55±0.05,均P<0.05),IκB-α/GAPDH(0.75±0.01)高于LPS组(0.54±0.06,P<0.05)。
证据类型、等级与局限
- 证据类型:动物实验(C57BL/6小鼠CLP脓毒症相关脑病模型)与细胞实验(BV-2小胶质细胞)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为NaB可拮抗LPS诱导的TLR4活化,抑制p-NF-κB p65核转录和IκB-α降解,减少小胶质细胞活化及炎症因子分泌,改善脓毒症小鼠海马炎症和远期焦虑样行为。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the effects of sodium butyrate (NaB) on long-term anxiety like behavior and inflammatory activation of microglia in the hippocampus of sepsis-associated encephalopathy (SAE) mice.
METHODS: (1) Animal experiment: fifty C57BL/6 mice aged 6-8 weeks were randomly divided into Sham group (only the cecum was found by laparotomy without perforation or ligation), and SAE model group caused by cecal ligation and puncture (CLP; SAE model group, the cecum was found by laparotomy and perforated after ligation. The open field test indicated that the ability of independent exploration decreased and showed anxiety like behavior, which proved that the SAE model was successfully replicated) and NaB pretreatment group was established (NaB was administered at a dose of 500 mg×kg-1×d-1 for 3 days before modeling, and the same dose once a day for 3 days after modeling). Open field test was used to detect the anxiety like behavior of mice at 7 days. The protein expressions and content changes of interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) in hippocampus of mice at 1 day and 3 days after operation were detected by Western blotting and enzyme linked immunosorbent assay (ELISA). Immunofluorescence staining was used to observe microglia labeled protein ionized calcium bindingadaptor molecule-1 (Iba-1) and TNF-α protein co localization. (2) Cell experiment: mouse microglia cell line BV-2 microglia were divided into blank control group, lipopolysaccharide (LPS) group (cells were treated with 1 mg/L LPS), and NaB treatment group (cells were treated with 1 mg/L LPS+5 mmol/L NaB). The protein expressions of IL-1β, TNF-α, Toll-like receptor 4 (TLR4), phosphorylated nuclear factor-κB p65 (p-NF-κB p65), nuclear factor-κB p65 (NF-κB p65) and NF-κB inhibitor protein-α (IκB-α) were detected by Western blotting. The expressions of Iba-1 and TNF-α in each group were observed by immunofluorescence.
RESULTS: (1) Animal experiment: compared with the Sham group, the distance and duration of movement in the central area, the total distance moved of mice decreased 7 days after the establishment of SAE model group were decreased [distance of movement in the central area (mm): 13.45±3.97 vs. 161.44±27.00, duration of movement in the central area (s): 1.82±0.58 vs. 13.45±2.17, the total distance moved (mm): 835.01±669.67 vs. 2 254.51±213.45, all P < 0.05]. In the hippocampus tissues of mice, a large number of nerve nuclei were pyknotic and deeply stained, and the arrangement of nerve cells was disordered. The cell bodies of microglia in mouse hippocampus increased significantly. The number of positive cells of Iba-1/TNF-α (Iba-1+/TNF-α+) increased significantly. The contents and protein expression of proinflammatory factors TNF-α, IL-1β in hippocampal homogenate supernatant 3 days after operation in SAE model group were significantly higher than those in Sham group [TNF-α (ng/L): 119.17±18.40 vs. 90.18±21.17, IL-1β (ng/L): 407.89±70.64 vs. 313.69±34.63; TNF-α/GAPDH: 1.42±0.50 vs. 0.80±0.08, IL-1β/GAPDH: 1.27±0.22 vs. 0.85±0.25, all P < 0.05]. After intragastric administration of NaB, the distance and duration of movement in the central area of mice were significantly higher than those in SAE model group [distance of movement in the central area (mm): 47.39±15.63 vs. 13.45±3.97, duration of movement in the central area (s): 6.12±1.87 vs. 1.82±0.58, all P < 0.05]. There was no significant change in the total distance moved (mm: 1 550.59±1 004.10 vs. 835.01±669.67, P > 0.05). The pyknosis and deep staining of nerve nuclei in mice were significantly less than those in SAE model group. The number of Iba-1+/TNF-α+ positive cells decreased significantly. The contents and protein expression levels of proinflammatory factors TNF-α, IL-1β in hippocampal homogenate supernatant 3 days after operation were significantly lower than those in SAE model group [TNF-α (ng/L): 64.95±9.10 vs. 119.17±18.40, IL-1β (ng/L): 311.94±69.92 vs. 407.89±70.64; TNF-α/GAPDH: 1.02±0.36 vs. 1.42±0.50, IL-1β/GAPDH: 0.86±0.20 vs. 1.27±0.22, all P < 0.05]. (2) Cell experiment: after LPS intervention, the fluorescence intensity of TNF-α in BV-2 cells was significantly enhanced, the protein expression levels of TNF-α, IL-1β, TLR4 and p-NF-κB p65 protein increased (TNF-α/GAPDH: 0.39±0.06 vs. 0.20±0.02, IL-1β/GAPDH: 0.27±0.03 vs. 0.19±0.01, TLR4/GAPDH: 0.55±0.12 vs. 0.33±0.09, p-NF-κB p65/NF-κB p65: 0.55±0.05 vs. 0.29±0.04, all P < 0.05), the expression level of IκB-α was lower than that in the control group(IκB-α/GAPDH: 0.54±0.06 vs. 0.81±0.03, P < 0.05). After NaB treatment, the fluorescence intensity of TNF-α in BV-2 cells was decreased. The protein expression levels of TNF-α, IL-1β, TLR4 and p-NF-κB p65 protein were significantly lower than that of LPS model group (TNF-α/GAPDH: 0.26±0.02 vs. 0.39±0.06, IL-1β/GAPDH: 0.11±0.04 vs. 0.27±0.03, TLR4/GAPDH: 0.28±0.14 vs. 0.55±0.12, p-NF-κB p65/NF-κB p65: 0.29±0.01 vs. 0.55±0.05, all P < 0.05), the protein expression level of IκB-α was significantly higher than that in the LPS group (IκB-α/GAPDH: 0.75±0.01 vs. 0.54±0.06, P < 0.05).
CONCLUSIONS: NaB could antagonism the TLR4 activation induced by LPS, thus inhibiting p-NF-κB p65 nuclear transcription and IκB-α degradation. It can reduce microglia activation and secretion of inflammatory factors, and finally improve the inflammation in the hippocampus of septic mice and long-term anxiety like behavior.
参考来源
- Zhang H, Fang H, Wang Y, et al. [Mechanisms of sodium butyrate inhibition of microglia inflammatory activation in hippocampus via Toll-like receptor 4/nuclear factor-κB p65 pathway]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021. PMID: 35131015. doi:10.3760/cma.j.cn121430-20211105-01647
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。